Skip to content

Economic Evaluation of Heart Failure Management in Colombian Clinics

Economic Evaluation of Heart Failure Management in Colombian Clinics

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01084564
Acronym
EconoHeart
Enrollment
300
Registered
2010-03-10
Start date
2008-01-31
Completion date
2008-06-30
Last updated
2010-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma, Heart Failure

Keywords

Cost-effectiveness analysis, Colombia

Brief summary

Cost effectiveness analysis of local management of patients diagnosed with heart failure disease compared with an ideal guideline-based management.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Asthma moderate to severe.

Design outcomes

Primary

MeasureTime frame
Incremental cost-effectiveness ratio from using Symbicort as symbicort as Maintenance and Reliever Therapy (SMART) when compared with its competitive alternatives
To determine cost-effectiveness of Heart Failure management in 3 Heart-specialized clinics in Bogotá Colombia12 months

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026